Ubiquitin carboxyl-terminal esterase L1 (UCHL1) is associated with stem-like cancer cell functions in pediatric high-grade glioma

被引:29
作者
Sanchez-Diaz, Patricia C. [1 ,2 ]
Chang, Judy C. [1 ]
Moses, Emily S. [1 ,3 ]
Dao, Tu [2 ]
Chen, Yidong [1 ,4 ]
Hung, Jaclyn Y. [1 ,5 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA
[2] Univ Incarnate Word, Rosenberg Sch Optometry, San Antonio, TX USA
[3] Univ Virginia, Dept Pediat, Charlottesville, VA USA
[4] Univ Texas Hlth Sci Ctr San Antonio, Epidemiol & Biostat, San Antonio, TX 78229 USA
[5] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, Div Hematol & Oncol, San Antonio, TX 78229 USA
来源
PLOS ONE | 2017年 / 12卷 / 05期
关键词
HYDROLASE L1; UCH-L1; DIFFERENTIATION; EXPRESSION; ONCOGENE; INVASION; PATHWAY; SYSTEM; ROLES; AKT;
D O I
10.1371/journal.pone.0176879
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pediatric high-grade gliomas represent 8 - 12% of all primary tumors of the nervous system in children. Five-year survival for these pediatric aggressive tumors is poor (15 - 35%) indicating the need to develop better treatments for pediatric high-grade gliomas. In this work we used SF188 and SJ-GBM2 cell lines to study the function of the ubiquitin carboxyl-terminal esterase L1 (UCHL1), a deubiquitinase de-regulated in several cancers, in pediatric high-grade gliomas. UCHL1 depletion in SF188 and SJ-GBM2 glioma cells was associated with decreased cell proliferation and invasion, along with a reduced ability to grow in soft agar and to form spheres (i.e. self-renewal measure). A 70% reduction in Wnt signaling was also observed in the SF188 and SJ-GBM2 UCHL1 knockdowns (KDs) using a TCF-dependent TOPflash reporter assay. Transcriptome comparisons of UCHL1 KDs versus vector control identified a list of 306 differentially expressed genes (at least 2-fold change; p < 0.05) which included genes known to be involved in cancer like ACTA2, POSTN, LIF, FBXL7, FBXW11, GDF15, HEY2, but also potential novel genes such us IGLL5, ABCA4, AQP3, AQP4, CALB1, and ALK. Bioinformatics gene ontology (GO) analysis of these 306 genes revealed significant enrichment in "signal peptides", "extracellular matrix" and "secreted proteins "GO Terms. "Angiogenesis and blood vessel development", "neuron differentiation/development ",cell adhesion", and "cell migration" also showed significant enrichment in our GO analysis. Top canonical pathways identified by Ingenuity Pathway Analysis (IPA) included "Clathrin-mediated Endocytosis Signaling" (p = 5.14x10 (-4)), "Virus Entry via Endocytic Pathways" (p = 6.15x 10(-4)), and "High Mobility Group-Box 1 (HMGB1) Signaling" (p = 6.15x10(-4)). While FGF2, IL1B, TNF and PDGFB were predicted as top upstream regulators (p < 2x10(-16)) of the UCHL1 KD-associated transcriptome. Aberrant expression of UCHL1 in pediatric high-grade gliomas may promote cell invasion, transformation, and self-renewal properties, at least in part, by modulating Wnt/Beta catenin activity. UCHL1 might act as an oncogene in glioma within the gene network that imparts stem-like characteristics to these cancer cells.
引用
收藏
页数:19
相关论文
共 15 条
  • [11] Ubiquitin carboxyl-terminal hydrolase L1 promotes hypoxia-inducible factor 1-dependent tumor cell malignancy in spheroid models
    Li, Xuebing
    Hattori, Akira
    Takahashi, Senye
    Goto, Yoko
    Harada, Hiroshi
    Kakeya, Hideaki
    CANCER SCIENCE, 2020, 111 (01) : 239 - 252
  • [12] Disturbed sleep/wake rhythms and neuronal cell loss in lateral hypothalamus and retina of mice with a spontaneous deletion in the ubiquitin carboxyl-terminal hydrolase L1 gene
    Pfeffer, Martina
    Plenzig, Stefanie
    Gispert, Suzana
    Wada, Keiji
    Korf, Horst-Werner
    Von Gall, Charlotte
    NEUROBIOLOGY OF AGING, 2012, 33 (02) : 393 - 403
  • [13] Small molecule inhibition of ubiquitin C-terminal hydrolase L1 alters cell metabolism proteins and exerts anti- or pro-tumorigenic effects contingent upon chemosensitivity status in high grade serous ovarian cancer
    Jansen, Corinne
    Mcadams, Julia
    Kim, Chloe
    de la Cruz, Payton
    Salaverria, Angelica
    Dasilva, Nicholas A.
    Grive, Kathryn
    James, Nicole E.
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [14] ALDH1-High Ovarian Cancer Stem-Like Cells Can Be Isolated from Serous and Clear Cell Adenocarcinoma Cells, and ALDH1 High Expression Is Associated with Poor Prognosis
    Kuroda, Takafumi
    Hirohashi, Yoshihiko
    Torigoe, Toshihiko
    Yasuda, Kazuyo
    Takahashi, Akari
    Asanuma, Hiroko
    Morita, Rena
    Mariya, Tasuku
    Asano, Takuya
    Mizuuchi, Masahito
    Saito, Tsuyoshi
    Sato, Noriyuki
    PLOS ONE, 2013, 8 (06):
  • [15] Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium
    Ruscito, Ilary
    Castillo-Tong, Dan Cacsire
    Vergote, Ignace
    Ignat, Iulia
    Stanske, Mandy
    Vanderstichele, Adriaan
    Ganapathi, Ram N.
    Glajzer, Jacek
    Kulbe, Hagen
    Trillsch, Fabian
    Mustea, Alexander
    Kreuzinger, Caroline
    Panici, Pierluigi Benedetti
    Gourley, Charlie
    Gabra, Hani
    Kessler, Mirjana
    Sehouli, Jalid
    Darb-Esfahani, Silvia
    Braicu, Elena Ioana
    EUROPEAN JOURNAL OF CANCER, 2017, 79 : 214 - 225